Erlotinib Tablets I.P. 150 mg Erlozest 3x10 Tablets

Erlotinib, the active ingredient in Erlozest 150mg Tablet, is a tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR). It is used to treat non-small cell lung cancer (NSCLC) and, in combination with gemcitabine, pancreatic cancer. Erlotinib works by inhibiting the EGFR pathway, thereby preventing cancer cell proliferation